Immunomodulatory activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA), a potent anti-HIV nucleotide analogue, on in vivo murine models

Vera Del Gobbo, Andrea Foli, Jan Balzarini, Erik De Clercq, Emanuela Balestra, Nicoletta Villani, Stefano Marini, Carlo Federico Perno, Raffaele Calio

Research output: Contribution to journalArticle

Abstract

In order to evaluate the influence of antiviral nucleoside analogues upon the natural immune system, we investigated the immunomodulatory activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA), a nucleotide analogue with potent anti-HIV and anti-herpes activity, in a murine system. C57BL/6 mice were inoculated intraperitoneally with 10, 25 and 50 mg PMEA/kg. Mononuclear cells were isolated from their spleens, and some natural immune functions were evaluated. The results show that PMEA significantly increases the levels of natural killer (NK)-cell cytotoxicity. We also found that α/β IFN production was substantially increased in PMEA-treated mice, while both IL-1 and IL-2 production was decreased. Thus, PMEA can increase some natural immunity functions, such as NK activity and IFN production. These results suggest that PMEA might be active in vivo against HIV and herpes viruses both as an immunomodulator and as an antiviral compound.

Original languageEnglish
Pages (from-to)65-75
Number of pages11
JournalAntiviral Research
Volume16
Issue number1
DOIs
Publication statusPublished - 1991

Keywords

  • 9-(2-Phosphonylmethoxyethyl)adenine
  • Interferon
  • Interleukin-1
  • Interleukin-2
  • NK cytotoxicity
  • Nucleotide analog

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Fingerprint Dive into the research topics of 'Immunomodulatory activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA), a potent anti-HIV nucleotide analogue, on in vivo murine models'. Together they form a unique fingerprint.

  • Cite this